Carsten Hirt

1.9k total citations
42 papers, 1.1k citations indexed

About

Carsten Hirt is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Carsten Hirt has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 19 papers in Oncology and 18 papers in Genetics. Recurrent topics in Carsten Hirt's work include Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Viral-associated cancers and disorders (11 papers). Carsten Hirt is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Viral-associated cancers and disorders (11 papers). Carsten Hirt collaborates with scholars based in Germany, United States and France. Carsten Hirt's co-authors include Gottfried Dölken, Frank Schüler, Gerald Illerhaus, R Mertelsmann, Thomas Kiefer, Charles S. Rabkin, Siegfried Janz, William Krüger, Mathias Freund and Christian A. Schmidt and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Carsten Hirt

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carsten Hirt Germany 18 774 449 433 197 181 42 1.1k
Margaret Shovlin United States 13 991 1.3× 639 1.4× 374 0.9× 323 1.6× 233 1.3× 28 1.3k
Pascale De Paepe Belgium 15 564 0.7× 387 0.9× 285 0.7× 84 0.4× 268 1.5× 36 999
Clémentine Sarkozy France 20 1.0k 1.3× 791 1.8× 371 0.9× 219 1.1× 263 1.5× 73 1.4k
King Tan Canada 15 1.1k 1.4× 812 1.8× 427 1.0× 327 1.7× 259 1.4× 31 1.5k
Alessandra Pucciarini Italy 14 691 0.9× 413 0.9× 413 1.0× 135 0.7× 475 2.6× 19 1.4k
Jocelyn Maragulia United States 16 993 1.3× 581 1.3× 325 0.8× 465 2.4× 93 0.5× 37 1.3k
David Belada Czechia 18 819 1.1× 604 1.3× 327 0.8× 175 0.9× 127 0.7× 167 1.1k
Nasser Z. Parsa United States 15 764 1.0× 486 1.1× 467 1.1× 123 0.6× 352 1.9× 22 1.2k
M. Michaela Ott Germany 18 994 1.3× 676 1.5× 481 1.1× 171 0.9× 138 0.8× 27 1.2k
Olga Balagué Spain 22 827 1.1× 686 1.5× 274 0.6× 161 0.8× 440 2.4× 51 1.6k

Countries citing papers authored by Carsten Hirt

Since Specialization
Citations

This map shows the geographic impact of Carsten Hirt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Hirt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Hirt more than expected).

Fields of papers citing papers by Carsten Hirt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Hirt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Hirt. The network helps show where Carsten Hirt may publish in the future.

Co-authorship network of co-authors of Carsten Hirt

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Hirt. A scholar is included among the top collaborators of Carsten Hirt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Hirt. Carsten Hirt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilhelm, Christian, Roland Moll, Jörg Jäkel, et al.. (2019). Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial. Journal of Cancer Research and Clinical Oncology. 145(8). 2149–2156. 4 indexed citations
2.
Hirt, Carsten, Sergio Iannazzo, Silvia Chiroli, et al.. (2019). Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia. Applied Health Economics and Health Policy. 17(4). 555–567. 4 indexed citations
3.
Stroux, Andrea, Carsten Hirt, Ulrich Keller, et al.. (2015). Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis. Annals of Hematology. 94(6). 981–988. 19 indexed citations
4.
Hirt, Carsten, M. Constanza Camargo, Kelly J. Yu, et al.. (2014). Risk of follicular lymphoma associated withBCL2translocations in peripheral blood. Leukemia & lymphoma. 56(9). 2625–2629. 7 indexed citations
5.
Hirt, Carsten, et al.. (2012). Identification of a glutathione peroxidase inhibitor that reverses resistance to anticancer drugs in human B-cell lymphoma cell lines. Bioorganic & Medicinal Chemistry Letters. 22(21). 6712–6715. 23 indexed citations
6.
Busemann, Christoph, Carsten Hirt, Michael Kirsch, et al.. (2012). Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation. Experimental Hematology and Oncology. 1(1). 32–32. 5 indexed citations
7.
8.
Schüler, Frank, Carsten Hirt, Thomas Kiefer, et al.. (2008). Prevalence and frequency of circulating t(14;18)‐MBR translocation carrying cells in healthy individuals. International Journal of Cancer. 124(4). 958–963. 70 indexed citations
9.
Rabkin, Charles S., Carsten Hirt, Siegfried Janz, & Gottfried Dölken. (2008). t(14;18) Translocations and Risk of Follicular Lymphoma. JNCI Monographs. 2008(39). 48–51. 23 indexed citations
10.
11.
Kiefer, Thomas, William Krüger, Michael Montemurro, et al.. (2008). Mobilization of hemopoietic stem cells with high‐dose methotrexate plus granulocyte–colony‐stimulating factor in patients with primary central nervous system lymphoma. Transfusion. 48(12). 2624–2628. 4 indexed citations
12.
Dölken, Gottfried, Lars Dölken, Carsten Hirt, et al.. (2008). Age-Dependent Prevalence and Frequency of Circulating t(14;18)-Positive Cells in the Peripheral Blood of Healthy Individuals. JNCI Monographs. 2008(39). 44–47. 28 indexed citations
13.
Hirt, Carsten, Gottfried Dölken, Siegfried Janz, & Charles S. Rabkin. (2007). Distribution of t(14;18)‐positive, putative lymphoma precursor cells among B‐cell subsets in healthy individuals1. British Journal of Haematology. 138(3). 349–353. 25 indexed citations
14.
Hirt, Carsten, et al.. (2007). Large deletions in the CFTR gene: clinics and genetics in Swiss patients with CF. Clinical Genetics. 72(1). 30–38. 9 indexed citations
15.
Kiefer, Thomas, Frank Schüler, A. Knopp, et al.. (2007). A human Burkitt’s lymphoma cell line carrying t(8;22) and t(14;18) translocations. Annals of Hematology. 86(11). 821–830. 7 indexed citations
16.
17.
Hirt, Carsten, Frank Schüler, & Gottfried Dölken. (2003). Minimal residual disease (MRD) in follicular lymphoma in the era of immunotherapy with rituximab. Seminars in Cancer Biology. 13(3). 223–231. 12 indexed citations
18.
Hirt, Carsten & Gottfried Dölken. (2000). Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation. Bone Marrow Transplantation. 25(4). 419–426. 40 indexed citations
19.
Dölken, Gottfried, Gerald Illerhaus, Carsten Hirt, & R Mertelsmann. (1996). BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases.. Journal of Clinical Oncology. 14(4). 1333–1344. 141 indexed citations
20.
Siméoni, Umberto, Thierry Massfelder, Carsten Hirt, et al.. (1994). Specific Developmental Profiles of Lysosomal and Brush Border Enzymuria in the Human. Neonatology. 65(1). 1–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret Shovlin Breakdown of academic impact, for papers by Pascale De Paepe Breakdown of academic impact, for papers by Clémentine Sarkozy Breakdown of academic impact, for papers by King Tan Breakdown of academic impact, for papers by Alessandra Pucciarini Breakdown of academic impact, for papers by Jocelyn Maragulia Breakdown of academic impact, for papers by David Belada Breakdown of academic impact, for papers by Nasser Z. Parsa Breakdown of academic impact, for papers by M. Michaela Ott Breakdown of academic impact, for papers by Olga Balagué
Rankless by CCL
2026